1. Home
  2. RSI vs HCM Comparison

RSI vs HCM Comparison

Compare RSI & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RSI

Rush Street Interactive Inc.

HOLD

Current Price

$32.21

Market Cap

2.6B

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$10.85

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RSI
HCM
Founded
2012
2000
Country
United States
Hong Kong
Employees
N/A
1796
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RSI
HCM
Price
$32.21
$10.85
Analyst Decision
Strong Buy
Sell
Analyst Count
10
1
Target Price
$28.20
$13.75
AVG Volume (30 Days)
3.2M
46.9K
Earning Date
04-28-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
933.33
N/A
EPS
0.08
N/A
Revenue
$1,134,428,000.00
N/A
Revenue This Year
$25.44
$20.60
Revenue Next Year
$14.27
$15.62
P/E Ratio
$408.25
$5.49
Revenue Growth
22.76
N/A
52 Week Low
$14.39
$9.77
52 Week High
$34.51
$19.50

Technical Indicators

Market Signals
Indicator
RSI
HCM
Relative Strength Index (RSI) 57.17 45.60
Support Level $25.56 $9.77
Resistance Level N/A $15.59
Average True Range (ATR) 1.23 0.29
MACD -0.09 0.10
Stochastic Oscillator 56.12 30.88

Price Performance

Historical Comparison
RSI
HCM

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: